Skip to main content
Retour
Watch Compare

Imunon, Inc.

Qualité des données : 83%
IMNN
NASDAQ Manufacturing Chemicals
3,15 €
▲ 0,05 € (1,61%)
6 months return
—
Momentum
Neutral
ROE
-430,02%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-430,02%
En dessous de la moyenne du secteur (-54,47%)
ROIC-280,21%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio1,73
Interest CoverageN/A

Valorisation

PE (TTM|NTM)
-0,82 | -0,93
Au-dessus de la moyenne du secteur (-1,50)
P/B Ratio2,93
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -14,18 M

Price History

Tendances Financières

Objectif de Cours des Analystes

4 analystes
Buy
+582.5%
upside to target
Actuel
3,15 €
Consensus Target
21,50 €
12,00 €
Bas
33,00 €
Haut
Prévisions
P/E Prévisionnel
-0,93
BPA Prévisionnel
-3,14 €
CA Est.
0,0

Surprises de Résultats

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -1,27 € · Rev Est: 0,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -3,65 € -1,87 € -1,16 € -1,30 € — —
Estimate -4,66 € -4,34 € -1,82 € -1,82 € -1,27 € -0,86 €
Surprise +21,68% +56,89% +36,36% +28,57% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -430,02% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -14,50 M
ROE -430,02% ROA -163,08%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -14,18 M
ROIC -280,21% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 1,73
Debt / Equity N/A Current Ratio 1,73
Interest Coverage N/A Asset Turnover N/A
Working Capital 3,06 M Tangible Book Value 4,08 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,82 · EV/EBITDA: N/A
P/E Ratio -0,82 Forward P/E -0,93
P/B Ratio 2,93 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -118,59%
Market Cap 11,95 M Enterprise Value 6,70 M

Per Share

EPS: -6,83 · FCF/Share: -3,61
EPS (Diluted TTM) -6,83 Revenue / Share N/A
FCF / Share -3,61 OCF / Share -3,54
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 97,81% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 97,81%
SBC-Adj. FCF -14,53 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — 500 000,0 500 000,0 500 000,0
Net Income -14,50 M -18,62 M -19,51 M -35,90 M -20,77 M
EPS (Diluted) -6,83 -1,62 -2,16 — —
Gross Profit — — — — —
Operating Income -14,65 M -19,13 M -21,03 M -24,92 M -21,01 M
EBITDA — — — — —
R&D Expenses 7,78 M 11,64 M 11,29 M 11,73 M 10,62 M
SG&A Expenses — — — — —
D&A — 240 000,0 248 000,0 731 629,0 702 918,0
Interest Expense — 197 080,0 197 080,0 5,03 M 569 881,0
Income Tax — -1,28 M -1,28 M -1,57 M -1,38 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 12,29 M 9,72 M 21,92 M 43,98 M 74,05 M
Total Liabilities 5,23 M 5,47 M 8,53 M 14,65 M 18,25 M
Shareholders' Equity 7,06 M 4,24 M 13,39 M 29,33 M 55,80 M
Total Debt — — — 5,96 M 5,85 M
Cash & Equivalents 8,78 M 5,87 M 5,84 M 11,49 M 19,59 M
Current Assets 10,72 M 8,01 M 18,24 M 37,15 M 51,95 M
Current Liabilities 4,62 M 4,79 M 7,39 M 10,04 M 6,77 M

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -0,8 -1,5
P/B 2,9 1,6
ROE % -430,0 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,7
D/E — 0,3